Personalized Cancer Vaccines Market: Emerging Technologies, Key Trends and Competitive Landscape
The Personalized Cancer Vaccines Market is characterized by a broad range of technologies and applications designed to support individualized cancer treatment. The market is projected to expand from USD 5.2 billion in 2025 to USD 25 billion by 2035, with a CAGR of 17.1%. By technology, the market includes dendritic cell vaccines, peptide vaccines, viral vector vaccines, and DNA vaccines....
0 Comments 0 Shares 57 Views 0 Reviews